Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;29(6):531-533.
doi: 10.5005/jp-journals-10071-24993. Epub 2025 Jun 5.

What Every Intensivist Should Know About Remimazolam

Affiliations

What Every Intensivist Should Know About Remimazolam

Rhythm Mathur et al. Indian J Crit Care Med. 2025 Jun.

Abstract

Remimazolam, a recently developed benzodiazepine, possesses characteristics that make it an optimal sedative drug. These characteristics include a quicker onset, improved recovery, organ-independent metabolism, absence of accumulation, and rapid reversal with Flumazenil.

How to cite this article: Mathur R, Chittoria K, Sharma A, Goyal S, Kothari N. What Every Intensivist Should Know About Remimazolam. Indian J Crit Care Med 2025;29(6):531-533.

Keywords: Intensive care unit; Remimazolam; Sedation.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: NoneConflict of interest: None

Figures

Fig. 1
Fig. 1
Use of remimazolam in the ICU patients

Similar articles

References

    1. Prabhakar H, Tripathy S, Gupta N, Singhal V, Mahajan C, Kapoor I, et al. Consensus statement on analgo-sedation in neurocritical care and review of literature. Indian J Crit Care Med. 2021;25(2):126–133. doi: 10.5005/jp-journals-10071-23712. - DOI - PMC - PubMed
    1. Harsha MS, Bhatia PK, Sharma A, Sethi P. Comparison of Quantium Consciousness Index and Richmond Agitation Sedation Scale in mechanically ventilated critically ill patients: An observational study. Indian J Crit Care Med. 2022;26(4):491–495. doi: 10.5005/jp-journals-10071-24183. - DOI - PMC - PubMed
    1. Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: An updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957–3974. doi: 10.2147/DDDT.S384155. - DOI - PMC - PubMed
    1. Kim SH, Fechner J. Remimazolam – current knowledge on a new intravenous benzodiazepine anesthetic agent. Korean J Anesthesiol. 2022;75(4):307–315. doi: 10.4097/kja.22297. - DOI - PMC - PubMed
    1. Chen H-Y, Wang X-X, Lu Y-G, Tang S-H, Ding T, Song J-C, et al. Comparison of the recovery time of remimazolam besylate and propofol for gastrointestinal endoscopy sedation in elderly patients. Int J Med Sci. 2024;21(7):1250–1256. doi: 10.7150/ijms.93045. - DOI - PMC - PubMed

LinkOut - more resources